JAMIE LAPORTE: Open Payments
NPI 1326322090 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,702 in 142 payments from 26 companies in 2025. Trend: 2023 $3,213 · 2024 $2,689 · 2025 $2,702
Food & beverage: $2,607Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $352 |
| ABBVIE INC. | 24 | $303 |
| UCB, Inc. | 13 | $244 |
| Galderma Laboratories, L.P. | 16 | $194 |
| Novartis Pharmaceuticals Corporation | 8 | $181 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $163 |
| GENZYME CORPORATION | 5 | $158 |
| LEO Pharma Inc. | 6 | $145 |
| Lilly USA, LLC | 11 | $143 |
| Amgen Inc. | 5 | $109 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, ADBRY, TALTZ, OTEZLA, COSENTYX.
Industry payments across PA — which companies pay providers there.
